TILT : a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individualsANGUS, Brian; LAMPE, Fiona; BABIKER, Abdul et al.AIDS (London). 2008, Vol 22, Num 6, pp 737-740, issn 0269-9370, 4 p.Article

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients. CommentaryGHOSN, Jade; WIRDEN, Marc; KATLAMA, Christine et al.AIDS (London). 2005, Vol 19, Num 15, pp 1643-1647, issn 0269-9370, 9 p.Article

Stopping antiretroviral therapy. CommentaryTAYLOR, Stephen; BOFFITO, Marta; KHOO, Saye et al.AIDS (London). 2007, Vol 21, Num 13, issn 0269-9370, 1673-1682, 1817-1818 [12 p.]Article

The Impact of Episodic CD4 Cell Count-Guided Antiretroviral Therapy on Quality of LifeBURMAN, William J; GRUND, Birgit; ROEDIGER, Mollie P et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 2, pp 185-193, issn 1525-4135, 9 p.Article

Intermittent antiretroviral therapy in patients with controlled HIV infectionMARCHOU, Bruno; TANGRE, Philippe; CHARREAU, Isabelle et al.AIDS (London). 2007, Vol 21, Num 4, pp 457-466, issn 0269-9370, 10 p.Article

Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: The retrogene studyRUIZ, Lidia; RIBERA, Esteban; TURAL, Cristina et al.The Journal of infectious diseases. 2003, Vol 188, Num 7, pp 977-985, issn 0022-1899, 9 p.Article

Therapeutic vaccination against HIV : current progress and future possibilitiesPULS, Rebekah L; EMERY, Sean.Clinical science (1979). 2006, Vol 110, Num 1, pp 59-71, issn 0143-5221, 13 p.Article

Kinetics of disappearance of resistance mutations and reappearance of wild-type during structured treatment interruptionsHALFON, Philippe; DURANT, Jacques; CLEVENBERGH, Philippe et al.AIDS (London). 2003, Vol 17, Num 9, pp 1351-1361, issn 0269-9370, 11 p.Article

CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAARTMAGGIOLO, Franco; AIROLDI, Monica; SUTER, Fredy et al.AIDS (London). 2009, Vol 23, Num 7, pp 799-807, issn 0269-9370, 9 p.Article

Costs of Intermittent Versus Continuous Antiretroviral Therapy in Patients With Controlled HIV Infection : A Substudy of the ANRS 106 Window TrialCHARREAU, Isabelle; JEANBLANC, Grégoire; TANGRE, Philippe et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 4, pp 416-421, issn 1525-4135, 6 p.Conference Paper

Favorable outcome of ex-vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV-1HASSON, Hamid; MANTELLI, Barbara; LAZZARIN, Adriano et al.Journal of medical virology. 2007, Vol 79, Num 11, pp 1640-1649, issn 0146-6615, 10 p.Article

Structured treatment interruption in patients with alveolar echinococcosisREUTER, Stefan; BUCK, Andreas; MANFRAS, Burkhard et al.Hepatology (Baltimore, Md.). 2004, Vol 39, Num 2, pp 509-517, issn 0270-9139, 9 p.Article

HIV-specific immunity during structured antiviral drug treatment interruptionMOSS, Ronald B; BRANDT, Carolyn; GIERMAKOWSKA, Wieslawa K et al.Vaccine. 2003, Vol 21, Num 11-12, pp 1066-1071, issn 0264-410X, 6 p.Article

Nonstructured Treatment Interruptions Among Injection Drug Users in Baltimore, MDKAVASERY, Ravi; GALAI, Noya; ASTEMBORSKI, Jacquie et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 4, pp 360-366, issn 1525-4135, 7 p.Article

Evaluation of HIV-1 Ambiguous Nucleotide Frequency During Antiretroviral Treatment InterruptionLI, Jonathan Z; CHRISTENSEN, Julie A; HONGYING WANG et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 61, Num 1, pp 19-22, issn 1525-4135, 4 p.Article

Interruptions of antiretroviral therapy in human immunodeficiency virus infection: are they detrimental to neurocognitive functioning?MUNOZ-MORENO, Jose A; FUMAZ, Carmina R; PRATS, Anna et al.Journal of neurovirology. 2010, Vol 16, Num 3, pp 208-218, issn 1355-0284, 11 p.Article

Interruption of antiretroviral therapy is associated with increased plasma cystatin CMOCROFT, Amanda; WYATT, Christina; ROSS, Michael et al.AIDS (London). 2009, Vol 23, Num 1, pp 71-82, issn 0269-9370, 12 p.Article

Virological and immunological stability in HIV infected patients undergoing partial-treatment interruptionMATA, Rosario C; FLOR-PARRA, Fernando; VICIANA, Pompeyo et al.Journal of clinical virology. 2009, Vol 45, Num 4, pp 362-366, issn 1386-6532, 5 p.Article

Effects of active treatment discontinuation in patients with a CD4⁺ T-cell nadir greater than 350 cells/mm³ : 48-week treatment interruption in early starters netherlands study (TRIESTAN)POGANY, Katalin; VANVALKENGOED, Irene G; BRINKMAN, Kees et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 4, pp 395-400, issn 1525-4135, 6 p.Article

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1 : results of the staccato randomised trialANANWORANICH, Jintanat; GAYET-AGERON, Angèle; CAVASSINI, Matthias et al.Lancet (British edition). 2006, Vol 368, Num 9534, pp 459-465, issn 0140-6736, 7 p.Article

The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection : Final results from a randomized clinical trial (Pulse)BLOCK, Mark T; MED, M; FINLAYSON, Robert J et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 2, pp 192-202, issn 1525-4135, 11 p.Article

HIV-1 coreceptor switch during 2 years of structured treatment interruptionsBARONCELLI, S; GALLUZZO, C. M; ANDREOTTI, M et al.European journal of clinical microbiology & infectious diseases (Print). 2013, Vol 32, Num 12, pp 1565-1570, issn 0934-9723, 6 p.Article

HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapyNICASTRI, Emanuele; DORI, Luca; SARMATI, Loredana et al.AIDS (London). 2012, Vol 26, Num 11, pp 1451-1452, issn 0269-9370, 2 p.Article

A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without RemuneANGEL, Jonathan B; ROUTY, Jean-Pierre; SEKALY, Rafick-Pierre et al.AIDS (London). 2011, Vol 25, Num 6, pp 731-739, issn 0269-9370, 9 p.Article

Response to planned treatment interruptions in HIV infection varies across childhoodEUROPEAN, Paediatric.AIDS (London). 2010, Vol 24, Num 2, pp 231-241, issn 0269-9370, 11 p.Article